The Korea Economic Daily
Byeongzu Ghang: drug responses vary by person; we will expand into pharmacogenomic data
Article summary
CEO Byeongzu Ghang explained plans to expand from polypharmacy management into the use of individual pharmacogenomic information.
The article describes prescribing-screen recognition, a drug interaction database, and technology to structure genomic test results for practical clinical use.
Source: The Korea Economic Daily
This is a summary of the article at publication. Select “View original” to read it within this page.
External originals are displayed in the language provided by their publisher.
